Synthesis and Biological Evaluation of Highly Active 7-Anilino Triazolopyrimidines as Potent Antimicrotubule Agents

Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries

(2021) Hyuna Sung et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Synthesis and biological evaluation of novel cabazitaxel analogues

(2021) Sumei Ren et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Discovery of highly potent tubulin polymerization inhibitors: Design, synthesis, and structure-activity relationships of novel 2,7-diaryl-[1,2,4]triazolo[1,5-a]pyrimidines

(2021) Xian-Sen Huo et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Anticancer Drugs for Intra-Arterial Treatment of Colorectal Cancer Liver Metastases: In-Vitro Screening after Short Exposure Time

(2021) Audrey Fohlen et al.   Pharmaceuticals

The multiple mechanisms of MCL1 in the regulation of cell fate

(2021) Hayley Widden et al.   Communications Biology

Design, synthesis and biological evaluation of 2-alkoxycarbonyl-3-anilinoindoles as a new class of potent inhibitors of tubulin polymerization

(2020) Romeo Romagnoli et al.   BIOORGANIC CHEMISTRY

Microtubule-targeting agents and their impact on cancer treatment

(2020) Vladimír Čermák et al.   EUROPEAN JOURNAL OF CELL BIOLOGY

The role of CDC25C in cell cycle regulation and clinical cancer therapy: a systematic review

(2020) Kai Liu et al.   Cancer Cell International

Bevacizumab plus fosbretabulin in recurrent ovarian cancer: Overall survival and exploratory analyses of a randomized phase II NRG oncology/gynecologic oncology group study

(2020) Krishnansu S. Tewari et al.   GYNECOLOGIC ONCOLOGY

The Mechanism of Tubulin Assembly into Microtubules: Insights from Structural Studies

(2020) Marcel Knossow et al.   iScience

Regulation of apoptosis in health and disease: the balancing act of BCL-2 family proteins

(2019) Rumani Singh et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Novel [1,2,4]triazolo[1,5-a]pyrimidine derivatives as potent antitubulin agents: Design, multicomponent synthesis and antiproliferative activities

(2019) Fang Yang et al.   BIOORGANIC CHEMISTRY

The Vascular Disrupting Agent CA4P Improves the Antitumor Efficacy of CAR-T Cells in Preclinical Models of Solid Human Tumors

(2019) Changwen Deng et al.   MOLECULAR THERAPY

Zebrafish Models of Cancer—New Insights on Modeling Human Cancer in a Non-Mammalian Vertebrate

(2019) Hason et al.   Genes

Microtubule dynamics: an interplay of biochemistry and mechanics

(2018) Gary J. Brouhard et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY

Microtubule-Targeting Agents: Strategies To Hijack the Cytoskeleton

(2018) Michel O. Steinmetz et al.   TRENDS IN CELL BIOLOGY

Transitions From Heart Disease to Cancer as the Leading Cause of Death in US States, 1999–2016

(2018) Michael C. Harding et al.   Preventing Chronic Disease

Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures

(2017) Wenlong Li et al.   Future Medicinal Chemistry

Novel Natural Product- and Privileged Scaffold-Based Tubulin Inhibitors Targeting the Colchicine Binding Site

(2016) Mengqi Dong et al.   MOLECULES

Design and Synthesis of Potent in Vitro and in Vivo Anticancer Agents Based on 1-(3′,4′,5′-Trimethoxyphenyl)-2-Aryl-1H-Imidazole

(2016) Romeo Romagnoli et al.   Scientific Reports

Recent Advancement in Discovery and Development of Natural Product Combretastatin-inspired Anticancer Agents

(2015) Pravin Patil et al.   Anti-Cancer Agents in Medicinal Chemistry

Natural antitubulin agents: Importance of 3,4,5-trimethoxyphenyl fragment

(2015) Arvind S. Negi et al.   BIOORGANIC & MEDICINAL CHEMISTRY

Stabilizing versus Destabilizing the Microtubules: A Double-Edge Sword for an Effective Cancer Treatment Option?

(2015) Daniele Fanale et al.   Analytical Cellular Pathology

Poly(ADP-ribose): A signaling molecule in different paradigms of cell death

(2014) Francesca Aredia et al.   BIOCHEMICAL PHARMACOLOGY

New Ligands of the Tubulin Colchicine Site Based on X-Ray Structures

(2014) Raquel Alvarez et al.   CURRENT TOPICS IN MEDICINAL CHEMISTRY

Recent developments in tubulin polymerization inhibitors: An overview

(2014) Ramandeep Kaur et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

Concise Synthesis and Biological Evaluation of 2-Aroyl-5-Amino Benzo[b]thiophene Derivatives As a Novel Class of Potent Antimitotic Agents

(2013) Romeo Romagnoli et al.   JOURNAL OF MEDICINAL CHEMISTRY

Synthesis and Biological Evaluation of 2-(Alkoxycarbonyl)-3-Anilinobenzo[b]thiophenes and Thieno[2,3-b]pyridines as New Potent Anticancer Agents

(2013) Romeo Romagnoli et al.   JOURNAL OF MEDICINAL CHEMISTRY

Discovery and Optimization of a Series of 2-Aryl-4-Amino-5-(3′,4′,5′-trimethoxybenzoyl)Thiazoles as Novel Anticancer Agents

(2012) Romeo Romagnoli et al.   JOURNAL OF MEDICINAL CHEMISTRY

Microtubule-targeted agents: When mitochondria become essential to chemotherapy

(2011) A. Rovini et al.   BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS

Synthesis and biological evaluation of 2-(3′,4′,5′-trimethoxybenzoyl)-3-aryl/arylaminobenzo[b]thiophene derivatives as a novel class of antiproliferative agents

(2010) Romeo Romagnoli et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

A phase I dose escalation study of TTI-237 in patients with advanced malignant solid tumors

(2010) Andrea Wang-Gillam et al.   INVESTIGATIONAL NEW DRUGS

How do anti-mitotic drugs kill cancer cells?

(2009) K. E. Gascoigne et al.   JOURNAL OF CELL SCIENCE

TTI-237: A Novel Microtubule-Active Compound with In vivo Antitumor Activity

(2008) C. F. Beyer et al.   CANCER RESEARCH

Induction of γ-globin mRNA, erythroid differentiation and apoptosis in UVA-irradiated human erythroid cells in the presence of furocumarin derivatives

(2007) Giampietro Viola et al.   BIOCHEMICAL PHARMACOLOGY